Abstract:PL03-01 Recent research in a variety of tumor systems has given support to the Cancer Stem Cell Hypothesis. Two important components of this hypothesis are that tumors originate in tissue stem or progenitor cells as a result of disregulation of the normally tightly regulated process of self-renewal. As a result of this, tumors contain and are driven by a cellular subcomponent that retains key stem cell properties including self-renewal which drives tumorigenesis and differentiation that contributes to cellular heterogeneity. The Cancer Stem Cell Hypothesis has profound implications for the early detection, prevention, and treatment of cancer. Our laboratory has developed techniques for the isolation and characterization of stem cells from human mammary glands and mammary carcinomas. Mammary stem and progenitor cells can be cultured in vitro as floating spherical colonies which we have termed which are composed of progenitor cells capable of multi-lineage differentiation, as well as stem cells capable of mammosphere formation. These more primitive cells express the stem cell markers OCT-4, Bmi-1, and ALDH-1. Mammosphere initiating cells which are estrogen receptor negative give rise to estrogen receptor positive proliferating progenitor We have utilized these in vitro systems as well as a humanized NOD-SCID mouse model to study the developmental pathways which regulate stem cell self-renewal and lineage specific commitment. Both Notch and Hedgehog signaling are involved in stem cell self-renewal as evidenced by the observation that activation of these pathways increases mammosphere number upon serial passage. These effects are mediated by the polycomb gene Bmi-1. Over expression of the Hedgehog component Gli-2 in mammosphere initiating cells results in the generation of ductal hyperplasias when these cells are implanted into the mammary fat pads of humanized NOD-SCID mice. In contrast, inhibition of Bmi-1 utilizing a siRNA lenti virus inhibits mammosphere formation in vitro and mammary gland development in these mice. These results suggest that disregulation of normal stem cell self-renewal results in expansion of stem cell pools which may then serve as targets for further transformational events. We have previously reported the isolation of a subpopulation of cells within human breast cancers which display stem cell characteristics. These cells characterized as CD44+ CD24 low lin- display activated Hedgehog signaling and increased expression of Bmi-1. In order to define markers which might prove useful for in situ characterization of normal and malignant mammary stem cells, we have examined the expression of aldehyde dehydrogenase (ALDH) an enzyme previously found to be expressed in hematopoietic and neuronal stem ALDH may be assessed by the Aldefluor assay which utilizes a fluorescent probe to detect cells displaying aldehyde dehydrogenase activity. We have found that the Aldefluor positive population of normal mammary epithelium has stem cell characteristics as demonstrated by mammosphere formation and generation of ductal alveolar structures in humanized NOD-SCID mice. Furthermore, in human mammary carcinoma xenografts, Aldeflour positive cells display properties of stem cells. As few as 200 Aldefluor positive cells, which comprise between 1-10% of the tumor cell population, produce tumors in NOD-SCID mice while 2x10 3 Aldefluor negative cells failed to generate tumors. Consistent with the Aldefluor positive population representing cancer stem cells, tumors generated from this population recapitulate the phenotypic heterogeneity of ALDH expression seen in the original tumor. Based on the above studies, we utilized immunochemistry to detect ALDH-1 as a marker of normal and malignant mammary stem/progenitor cells in situ. ALDH-1 antibodies detect a rare cell population in normal human mammary gland and in mammospheres generated from these Expanded ALDH-1 positive populations are found in pre-malignant lesions such as ductal carcinoma in situ (DCIS) and at areas of microinvasion. Furthermore, utilizing tumor tissue microarrays, we have determined that expression of ALDH-1 is associated with a poor clinical outcome. These studies demonstrate that ALDH-1 may be utilized to detect normal and malignant human mammary stem/progenitor cells providing a new tool for the early detection of beast cancer. Furthermore, since these cells may drive carcinogenesis, strategies aimed at their elimination, represents a rational approach for cancer prevention.

Abstract 3330: MicroRNA100 Regulates Breast Cancer Stem Cells

Abstract 3310: Micrornas Regulate the Transition Between EMT and MET Breast Cancer Stem Cell States

Microrna100 Inhibits Self-Renewal of Breast Cancer Stem-Like Cells and Breast Tumor Development

Abstract 13: Regulation of Breast Cancer Stem Cells by Mir-93

Supplementary Table 2 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Abstract 3327: Role of Microrna221 in Breast Cancer Stem Cell Expansion and Induction of EMT

Supplementary Figures 1 - 15 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Role of microRNAs in the Regulation of Breast Cancer Stem Cells

MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells

Supplementary Table 1 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

Supplementary Materials and Methods from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

The Influence of Mir-34A Expression on Stemness and Cytotoxic Susceptibility of Breast Cancer Stem Cells

Abstract 1945: Identification of a miRNA/mRNA network driving non-small cell lung cancer (NSCLC) dissemination

Identification Of A Mirna/Mrna Network Driving Non-Small Cell Lung Cancer (Nsclc) Dissemination

Abstract #2544: Mir191 Reprogrames Gene Expression to Control Invasiveness of Breast Cancer

Abstract 4726: Identification of efficacy biomarkers for therapies targeting miR-10b

Transfer of Mir-100 and Mir-125B Increases 3D Growth and Invasiveness in Recipient Cancer Cells

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic

Mir-100 Maintains Phenotype of Tumor-Associated Macrophages by Targeting Mtor to Promote Tumor Metastasis Via Stat5a/IL-1ra Pathway in Mouse Breast Cancer

Implications of the Cancer Stem Cell Hypothesis for the Early Detection and Prevention of Breast Cancer.